Recent Finacing
Recent Raise
TechnoVax develops virus-like particle vaccines for influenza, RSV, parainfluenza, HIV, and oncology indications, advancing influenza VLP candidates from preclinical development toward clinical testing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor